CONTEXT THERAPEUTICS INC (CNTX) Forecast, Price Target & Analyst Ratings

NASDAQ:CNTX • US21077P1084

Current stock price

2.26 USD
-0.17 (-7%)
At close:
2.2898 USD
+0.03 (+1.32%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CONTEXT THERAPEUTICS INC (CNTX).

Forecast Snapshot

Consensus Price Target

Price Target
$6.12
+ 170.80% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.12
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.75%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.12
Upside
+ 170.80%
From current price of $2.26 to mean target of $6.12, Based on 16 analyst forecasts
Low
$4.04
Median
$5.61
High
$9.45

Price Target Revisions

1 Month
20.00%
3 Months
2.86%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for CNTX. The average price target is 6.12 USD. This implies a price increase of 170.8% is expected in the next year compared to the current price of 2.26.
The average price target has been revised upward by 2.86% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CNTX Current Analyst RatingCNTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

CNTX Historical Analyst RatingsCNTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
83.75%
CNTX was analyzed by 16 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CNTX.
In the previous month the buy percentage consensus was at a similar level.
CNTX was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-24D. Boral CapitalMaintains Buy -> Buy
2026-03-24GuggenheimReiterate Buy -> Buy
2026-03-24Piper SandlerMaintains Overweight -> Overweight
2025-12-22Jones TradingInitiate Buy
2025-11-06D. Boral CapitalMaintains Buy -> Buy
2025-11-06HC Wainwright & Co.Maintains Buy -> Buy
2025-10-16D. Boral CapitalMaintains Buy -> Buy
2025-10-02Cantor FitzgeraldInitiate Overweight
2025-09-18GuggenheimInitiate Buy
2025-08-07D. Boral CapitalMaintains Buy -> Buy
2025-08-07HC Wainwright & Co.Maintains Buy -> Buy
2025-06-26Piper SandlerReiterate Overweight -> Overweight
2025-05-08D. Boral CapitalMaintains Buy -> Buy
2025-04-29D. Boral CapitalMaintains Buy -> Buy
2025-04-21William BlairInitiate Outperform
2025-04-09D. Boral CapitalMaintains Buy -> Buy
2025-03-21D. Boral CapitalMaintains Buy -> Buy
2025-03-21HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-15D. Boral CapitalMaintains Buy -> Buy
2025-01-08JMP SecuritiesInitiate Market Outperform
2024-11-25D. Boral CapitalInitiate Buy
2024-09-23HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-16Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.12
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-139.35%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-3.12%
EPS (3 Months)
-4.99%

Next Earnings Summary

CNTX is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.12 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CNTX revenue by date.CNTX revenue by date.
N/AN/AN/AN/A
307.43%		N/A
184.51%		N/A
124.40%		N/A
69.68%		N/A
53.50%
EBITDA
YoY % growth
CNTX ebitda by date.CNTX ebitda by date.
-33.19M-24.04M
27.57%		N/AN/AN/A-15.37M
-43.23%		-25.061M
-63.05%		-29.913M
-19.36%		-39.686M
-32.67%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CNTX ebit by date.CNTX ebit by date.
-33.23M-24.06M
27.60%		-5.38M-2.57M
52.23%		-10.53M
-309.73%		-15.38M
-46.06%		-25.073M
-63.02%		-29.924M
-19.35%		-39.703M
-32.68%		N/A
-8.14%		N/A
-22.85%		N/A
-16.31%		N/A
23.39%		N/A
100.45%		N/A
51,016.43%		N/A
132.28%		N/A
72.38%
Operating Margin
CNTX operating margin by date.CNTX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CNTX eps by date.CNTX eps by date.
N/AN/AN/AN/AN/A-0.93
90.13%		-1.50
-61.29%		-0.53
64.67%		-0.38
28.30%		N/A
-21.59%		N/A
5.08%		N/A
-32.83%		N/A
74.09%		N/A
308.11%		N/A
296.92%		N/A
71.78%		N/A
63.57%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.12
-139.35%		-0.11
-25.80%		-0.11
-14.92%		-0.12
12.73%		-0.11
6.25%		-0.10
9.91%		-0.11
2.37%		-0.13
-2.96%		-0.19
-70.45%		-0.21
-105.00%		-0.20
-82.27%		-0.20
-59.33%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-11.53M
-108.53%		-11.205M
-14.82%		-11.556M
-8.91%		-11.96M
13.36%		-12.481M
-8.25%		-13.272M
-18.45%		-13.783M
-19.27%		-14.166M
-18.45%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CNTX Yearly Revenue VS EstimatesCNTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 200M 400M 600M
CNTX Yearly EPS VS EstimatesCNTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4 -6 -8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-15.31%
EPS Next 5 Year
23.10%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CONTEXT THERAPEUTICS INC / CNTX Forecast FAQ

What do analysts expect the price target to be for CONTEXT THERAPEUTICS INC (CNTX)?

16 analysts have analysed CNTX and the average price target is 6.12 USD. This implies a price increase of 170.8% is expected in the next year compared to the current price of 2.26.

When does CONTEXT THERAPEUTICS INC (CNTX) report earnings?

CONTEXT THERAPEUTICS INC (CNTX) will report earnings on 2026-05-13.

Can you provide the consensus estimates for CONTEXT THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of CONTEXT THERAPEUTICS INC (CNTX) is -0.12 USD and the consensus revenue estimate is 0 USD.

Can you provide the consensus rating for CONTEXT THERAPEUTICS INC stock?

The consensus rating for CONTEXT THERAPEUTICS INC (CNTX) is 83.75 / 100 . This indicates that analysts generally have a positive outlook on the stock.